dalteparin has been researched along with Diabetes Mellitus, Type 1 in 6 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Artico, M | 1 |
| Massa, R | 1 |
| Cavallotti, D | 1 |
| Franchitto, S | 1 |
| Cavallotti, C | 1 |
| Roffi, M | 1 |
| Eberli, FR | 1 |
| Raynaud, A | 1 |
| Novelli, L | 1 |
| Rovani, X | 1 |
| Carreres, T | 1 |
| Bourquelot, P | 1 |
| Hermelin, A | 1 |
| Angel, C | 1 |
| Beyssen, B | 1 |
| Fatima, S | 1 |
| Watson, J | 1 |
| Douek, I | 1 |
| Fox, R | 1 |
| Kalani, M | 1 |
| Apelqvist, J | 1 |
| Blombäck, M | 1 |
| Brismar, K | 1 |
| Eliasson, B | 1 |
| Eriksson, JW | 1 |
| Fagrell, B | 1 |
| Hamsten, A | 1 |
| Torffvit, O | 1 |
| Jörneskog, G | 1 |
| Nielsen, S | 1 |
| Schmitz, A | 1 |
| Bacher, T | 1 |
| Rehling, M | 1 |
| Ingerslev, J | 1 |
| Mogensen, CE | 1 |
1 review available for dalteparin and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Diabetes and acute coronary syndromes.
Topics: Acute Coronary Syndrome; Anticoagulants; Aspirin; Blood Glucose; Clopidogrel; Diabetes Mellitus; Dia | 2009 |
2 trials available for dalteparin and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Effect of dalteparin on healing of chronic foot ulcers in diabetic patients with peripheral arterial occlusive disease: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Age of Onset; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Body Mass Index; Dalteparin; Dia | 2003 |
Transcapillary escape rate and albuminuria in Type II diabetes. Effects of short-term treatment with low-molecular weight heparin.
Topics: Adult; Aged; Albuminuria; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Capi | 1999 |
3 other studies available for dalteparin and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Morphological changes in the sciatic nerve of diabetic rats treated with low molecular weight heparin OP 2123/parnaparin.
Topics: Animals; Anticoagulants; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Angiop | 2002 |
Radiocephalic fistula complicated by distal ischemia: treatment by ulnar artery dilatation.
Topics: Aged; Angioplasty, Balloon; Arterial Occlusive Diseases; Catheters, Indwelling; Clopidogrel; Diabete | 2010 |
Limitation of proteinuria rise in diabetic pregnancy: possible benefits of enoxaparin.
Topics: Adult; Anticoagulants; Diabetes Mellitus, Type 1; Enoxaparin; Female; Humans; Pregnancy; Pregnancy i | 2010 |